Dr. Eric E. Bouhassira's lab at Albert Einstein College of Medicine focuses on developing new methods to produce cultured red blood cells (cRBCs) from stem cells. This innovative research aims to improve transfusion therapies, especially for patients with sickle cell disease by creating reliable sources of red blood cells with known antigen profiles. The work promises significant advancements in addressing the challenges of alloimmunization and providing effective transfusion support.

Dr. Wenjun Guo's lab at Albert Einstein College of Medicine focuses on understanding how certain breast cancer cells evade the immune system and progress into aggressive cancers. The lab studies basal-like breast cancer, which significantly affects younger women and those with specific genetic backgrounds. The aim is to identify new strategies to prevent this type of cancer by targeting early-stage stem-like cells that play a crucial role in cancer development.

Dr. Teresa V. Bowman's lab at Albert Einstein College of Medicine investigates how genetic mutations affect the blood system, focusing particularly on conditions like myelodysplastic syndromes (MDS). By using zebrafish models, the lab explores the role of specific genes and environmental factors in the development and function of hematopoietic stem and progenitor cells, which are crucial for blood cell production. The research aims to uncover insights that could lead to better understanding and treatment of blood disorders, particularly in older adults.

Dr. Shanye Yin's lab focuses on understanding how HIV and HPV interact to influence the development of oropharyngeal cancer, a type of throat cancer. By investigating the role of immune cells, particularly CD8+ T cells, in patients co-infected with these viruses, the lab aims to uncover new strategies for preventing and treating cancer in individuals living with HIV. Their research combines advanced techniques like single-cell sequencing and innovative mouse models to provide insights that could lead to improved therapies for affected patients.

Kristy Stengel's lab focuses on understanding how the RUNX1 transcription factor regulates the development of blood cells and its links to blood disorders, such as familial platelet disorder and blood cancer. The lab utilizes innovative techniques to examine how RUNX1 interacts with other proteins to control gene expression that is critical for blood cell formation and function. By employing cell lines and engineered mouse models, they aim to uncover the mechanisms behind RUNX1's role in hematopoiesis, contributing to our understanding of genetic blood conditions.

Dr. Dmitry Fyodorov's lab at Albert Einstein College of Medicine focuses on understanding how sperm chromatin is structured and remodeled during the development of sperm and the process of fertilization. By studying the unique features of sperm chromatin—especially how it differs from chromatin in other cell types—his team aims to uncover mechanisms that may inform treatments for fertility issues and develop new contraceptives. The research combines molecular biology, biophysics, and genetics using the fruit fly as a model organism.

Dr. Maria Marianovich's lab studies how the sympathetic nervous system influences the aging of blood-forming stem cells within the bone marrow. They aim to uncover the mechanisms that govern stem cell function and their environment as we age, which is crucial for understanding blood disorders and potential therapeutic strategies. Her research involves cutting-edge techniques and aims to reveal how nerve signals affect stem cell health and longevity.

Dr. Keisuke Ito's lab focuses on understanding the role of the Tet2 gene in hematopoietic stem cells, which are essential for producing blood cells. They study how mutations in Tet2 can lead to disorders like myelodysplastic syndrome (MDS), a disease where blood production is impaired. By using genetically modified mouse models, the lab aims to uncover the molecular mechanisms by which Tet2 functions, contributing to better treatments for blood-related diseases.

Dr. Zijie Sun's lab at Albert Einstein College of Medicine focuses on understanding the biological mechanisms behind prostate cancer, particularly in African American men. The research aims to explore how genetic variations in androgen signaling pathways contribute to the higher incidence and mortality of prostate cancer in this population. By using advanced animal models and cutting-edge techniques like single-cell RNA sequencing, the lab aims to uncover new strategies for prevention and treatment.

Dr. U Thomas Meier's lab focuses on how the nucleolus, a crucial part of the cell that produces ribosomes, works and how its dysfunction can lead to diseases like dyskeratosis congenita. The team investigates the processes involved in ribosomal RNA modification, aiming to understand how these processes contribute to diseases and finding potential therapeutic interventions. This research could unveil new treatment strategies for patients with blood cell production disorders.

Dr. Louis M. Weiss's research lab focuses on understanding Toxoplasma gondii, a parasite that causes severe brain infections in individuals with HIV/AIDS. The lab investigates the cyst wall of this parasite, which is crucial for its ability to persist and reactivate in the central nervous system. By identifying proteins that comprise this cyst wall and exploring their roles, the lab aims to develop new strategies for preventing opportunistic infections in immunocompromised patients.